The Effect of Sphenopalatine Ganglion Block on Headache and Vasalgia
1 other identifier
interventional
42
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of sphenopalatine ganglion block (SPG block) on headache and veisalgia (hangover) the day after attending the metal festival Copenhell.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2025
CompletedFirst Submitted
Initial submission to the registry
June 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 11, 2025
CompletedJuly 11, 2025
July 1, 2025
3 days
June 23, 2025
July 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Headache Pain Intensity 10 minutes after SPGB
Pain intensity (0-100 mm on a visual analog scale, VAS) of the headache in a standing position 10 minutes after administration of the block in the Ropivacaine-Lidocaine group and the Sham group. Pain intensity is measured as the worst pain experienced after the person has been standing for 30 seconds, or as the worst pain during the attempt to stand if the test must be aborted.
10 minutes following block
Secondary Outcomes (4)
Pain score below 30mm (VAS)
10 minutes following block
Difference in headache pain intensity in standing position
10 minutes following block
Severity of veisalgia
10 minutes following block
Difference in veisalgia severity
10 minutes following block
Study Arms (2)
Block (Lidocaine + Ropivacaine)
EXPERIMENTALSham block (Saline)
SHAM COMPARATORIncomplete block with saline (no contact with ganglion)
Interventions
A bilateral transnasal sphenopalatine ganglion block with cotton tips soaked in a mixture of 0.5 mL lidocaine 4% and 0.5 mL ropivacaine 0.5% plus injection through the cotton tips of an additional 1 mL of the mixture. The Danish Medicines Agency waived need for approval as this procedure is not considered a pharmaceutical intervention.
A sham block with two bilaterally inserted cotton tips not reaching the posterior part of the nasopharyngeal making not contact with the ganglion. Cotton tips are soaked in 1 mL placebo (saline) and have a total of 1 mL saline injected through the cotton tips. The Danish Medicines Agency waived need for approval as this procedure is not considered a pharmaceutical intervention.
Eligibility Criteria
You may qualify if:
- Meets screening criteria and is present on the day of intervention
- Moderate to severe headache (defined as ≥ 3 on a 0-10 VAS) on the day of intervention
You may not qualify if:
- Intake of alcohol or other intoxicating substances after waking up on the day of intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Copenhell 2025
Copenhagen, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Professor
Study Record Dates
First Submitted
June 23, 2025
First Posted
July 11, 2025
Study Start
June 18, 2025
Primary Completion
June 21, 2025
Study Completion
June 21, 2025
Last Updated
July 11, 2025
Record last verified: 2025-07